BENCIVENGA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.757
EU - Europa 1.684
AS - Asia 775
AF - Africa 23
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.258
Nazione #
US - Stati Uniti d'America 1.750
CN - Cina 521
GB - Regno Unito 441
IT - Italia 228
IE - Irlanda 213
SE - Svezia 210
FR - Francia 162
RU - Federazione Russa 155
SG - Singapore 100
DE - Germania 95
FI - Finlandia 75
VN - Vietnam 53
UA - Ucraina 34
JP - Giappone 33
KR - Corea 27
RW - Ruanda 21
AT - Austria 18
BE - Belgio 15
HK - Hong Kong 13
NL - Olanda 10
AU - Australia 8
CA - Canada 7
TW - Taiwan 6
ES - Italia 5
IL - Israele 5
CZ - Repubblica Ceca 3
EU - Europa 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
TR - Turchia 3
AZ - Azerbaigian 2
BR - Brasile 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
IN - India 2
KG - Kirghizistan 2
LU - Lussemburgo 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
Totale 4.258
Città #
Southend 413
Chandler 407
Dublin 209
Jacksonville 156
Ashburn 126
Beijing 120
Verona 94
Ann Arbor 92
Redmond 78
New York 77
Woodbridge 73
Lawrence 62
Princeton 62
Houston 60
Singapore 57
Jinan 53
Wilmington 48
Helsinki 44
Nanjing 42
Shenyang 37
Tokyo 30
Hebei 27
Seoul 27
Sindelfingen 27
Dong Ket 24
Los Angeles 23
Kigali 21
Changsha 18
Tianjin 17
Falls Church 16
Haikou 16
Brussels 15
Guangzhou 15
Nanchang 15
Ningbo 14
Taizhou 14
Dallas 13
Hong Kong 13
Milan 13
Seattle 13
Vienna 12
Zhengzhou 12
Jiaxing 11
Washington 11
Hangzhou 10
Fuzhou 9
Lappeenranta 9
Amsterdam 8
Boardman 8
Moscow 8
Redwood City 8
Auburn Hills 6
Erba 6
Lancaster 6
Norwalk 6
Renton 6
San Francisco 6
Tombolo 6
Bologna 4
Cagliari 4
Klagenfurt 4
Paris 4
Sant'Ambrogio di Valpolicella 4
Tel Aviv 4
Adelaide 3
Colombo 3
Detroit 3
Dongguan 3
Frankfurt am Main 3
Kent 3
Lima 3
Melbourne 3
Mira 3
Oslo 3
San Diego 3
Toronto 3
Trento 3
Ancona 2
Athens 2
Baku 2
Bassano del Grappa 2
Berlin 2
Bishkek 2
Boydton 2
Brno 2
Cairo 2
Caneva 2
Chions 2
Clearwater 2
Columbus 2
Council Bluffs 2
Düsseldorf 2
Falkenstein 2
Fortaleza 2
Gipuzkoa 2
Grafing 2
Groningen 2
Kemerovo 2
Lanzhou 2
Linz 2
Totale 2.938
Nome #
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 132
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 129
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 124
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 121
Genomic characterization of hepatoid tumors: context matters 106
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 99
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 96
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 89
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 88
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 86
Lymphadenectomy for gastric cancer at European specialist centres 84
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 83
Short-term and long-term risk factors in gastric cancer 83
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 82
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 81
Western strategy for EGJ carcinoma 77
Lymphadenectomy: how to do it? 77
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 76
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 71
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 70
Management of critically ill surgical patients Case reports 70
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 69
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 69
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 69
Complications after gastrectomy for cancer: Italian perspective 68
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 68
Clinical pathways in gastric cancer care 68
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 67
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 64
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 64
Methylation Dynamics of RASSF1A and Its Impact on Cancer 62
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 62
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 62
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 58
Tailored treatment for signet ring cell gastric cancer 57
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 57
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 55
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 55
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 53
Surgical treatment of hepatic metastases from gastric cancer 53
An aggressive early gastric cancer: Kodama's PenA type 52
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 47
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 47
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 47
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 47
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 46
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 46
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 44
Personalized therapeutic strategies in HER2-driven gastric cancer 44
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 43
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 42
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 42
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 41
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 40
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 40
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 39
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 38
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 37
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 34
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 34
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 34
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 32
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 28
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 27
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 25
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 23
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 22
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 18
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 18
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 17
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 17
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 17
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 17
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 15
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 13
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 13
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 12
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 12
Prophylactic Total Gastrectomy: Techniques 11
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 11
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 11
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 10
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 10
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 8
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 8
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 7
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 7
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 7
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 6
Totale 4.410
Categoria #
all - tutte 18.832
article - articoli 18.147
book - libri 0
conference - conferenze 266
curatela - curatele 0
other - altro 333
patent - brevetti 0
selected - selezionate 0
volume - volumi 86
Totale 37.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020423 0 0 3 20 51 28 65 45 16 52 49 94
2020/2021511 83 63 20 81 58 47 4 5 21 10 66 53
2021/2022534 25 120 26 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/2025209 94 97 18 0 0 0 0 0 0 0 0 0
Totale 4.410